Focus on Legal and Policy Barriers to HIV Services
FOR RELEASE
Monday, 18 July
2016
13:30PM SAST
AIDS 2016 Focuses on Impact of Legal And Policy Barriers To HIV Services for Groups at Greatest Risk of Infection
Durban, South
Africa – In an official press conference today at
the 21st International AIDS Conference (AIDS 2016) in
Durban, researchers and community representatives discussed
the impact of discriminatory laws and policies in many parts
of the world that hinder access to HIV prevention,
treatment, and care for the populations most at risk of HIV
infection – men who have sex with men, transgender people,
sex workers, people who inject drugs, and prisoners.
The latest data from UNAIDS show that these vulnerable populations account for more than one-third of all new HIV infections globally. Compared to the general population: transgender people are 49 times more likely to be living with HIV; men who have sex with men and people who inject drugs are each 24 times more likely to become infected with HIV; sex workers are 10 times more likely to become infected; and prisoners are five times more likely to be living with HIV.
“We will not end AIDS without addressing the needs of the most vulnerable individuals and communities, yet far too many are currently being left behind,” said Chris Beyrer, AIDS 2016 International Chair and President of the International AIDS Society. “Protecting human rights is not just a moral issue, it is a scientific issue. Research presented at this conference will demonstrate that exclusion and discrimination help fuel the spread of HIV.”
Beyrer recently served on a special Johns Hopkins University–Lancet Commission on Drug Policy and Health. He was lead author of the Commission’s final report, published in March 2016 in advance of the UN Special Session on the World Drug Problem. The report concluded in part that drug laws intended to protect have instead contributed to disease transmission, discrimination, lethal violence, and forced displacement, and have undermined people's right to health.
“Dealing effectively with HIV will require our communities and societies to break down longstanding prejudice, hatred, and ignorance,” said Justice Edwin Cameron of the Constitutional Court of South Africa. “Only when scientific advances are matched by social and cultural progress can this epidemic truly be contained.”
Other press conference speakers included Nigerian LGBT activist Bisi Alimi, President of the Global Network of Sex Work Projects Pye Jakobsson, and Chair of the Asia Pacific Transgender Network Abhina Aher. In addition,Frances Cowan of University College London discussed the results of one of the largest randomised trials ever conducted among female sex workers:
SAPPH-IRe intervention empowers female sex workers: The SAPPH-Ire trial was conducted among female sex workers (FSW) embedded within Zimbabwe’s National FSW Programme, Sisters, which provides sex-worker friendly services, free HIV testing, referral to government health services for ART, contraception, condoms, management of sexually transmitted infections, health education, and legal advice, all supported by peer educators. In addition to the services provided by Sisters,SAPPH-IRe sites provided intensified community mobilisation, onsite ART and PrEP, mobile phone SMS reminders to promote repeat HIV testing, and community-based adherence support to improve engagement with enhanced prevention and care. The primary outcome was the proportion of all FSW with detectable viral load (VL>1000 copies/ml) after 21 months. A baseline survey was completed in November 2013 (n=2,722 FSW, 57.5% HIV-positive, 50.5% HIV-positive and with viral load >1000 copies /ml) and a separate endline survey was conducted in April 2016. Secondary outcomes showed more than double the number of HIV tests at SAPPH-IRe sites compared to Sisters (2,606 vs. 1,151) and increased programme activity for all services, including onsite ART and PrEP initiations. [Summary based on submitted abstract; final results, including proportion of FSW with detectable viral load, expected to be presented on site.]
• Abstract: Results of the SAPPH-IRe trial: a cluster randomised trial of a combination intervention to empower female sex workers in Zimbabwe to link and adhere to antiretrovirals for treatment and prevention
• Session: Latebreaker
Session (Session Room 6, Tuesday 19 July 13:00-14:00
SAST)
###
About the International AIDS
Conference
The International AIDS Conference is the
largest conference on any global health or development
issue. First convened during the peak of the AIDS epidemic
in 1985, this conference continues to provide a unique forum
for the intersection of science and advocacy, and an
opportunity to strengthen policies and programmes to ensure
an evidence-based response to the epidemic. The conference
also serves as a focal point to intensify political and
financial commitments to AIDS. The 21st International AIDS
Conference (AIDS 2016) is being held in Durban, South Africa
(18-22 July 2016).
AIDS 2016 Conference Organizers
AIDS 2016 is organized by the International AIDS Society
in partnership with the Global Network of People Living with
HIV (GNP+); the International Council of AIDS Service
Organizations (ICASO); the International Community of Women
Living with HIV/AIDS (ICW Global), and the Joint United
Nations Programme on HIV/AIDS (UNAIDS). Non-permanent
partners are ICW Eastern Africa and the Men who Have Sex
with Men Global Forum (MSMGF). Local partners are the South
Africa National AIDS Council, the Department of Health for
the Republic of South Africa, and the South African Medical
Research Council (SAMRC). Regional partners are the AIDS
Rights Alliance for Southern Africa (ARASA), Enda Santé,
and Réseau Africain des Praticiens Assurant la Prise en
Charge Médicale des Personnes Vivant avec le VIH/SIDA
(RESAPSI).
About the International AIDS
Society
Founded in 1988, the International AIDS Society
(IAS) is the world’s largest association of HIV
professionals, with members from more than 180 countries.
IAS members work on all fronts of the global response to
AIDS and include researchers, clinicians, policy and
programme planners, and public health and community
practitioners.